Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 355

1.

Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI.

Mulay SR, Honarpisheh MM, Foresto-Neto O, Shi C, Desai J, Zhao ZB, Marschner JA, Popper B, Buhl EM, Boor P, Linkermann A, Liapis H, Bilyy R, Herrmann M, Romagnani P, Belevich I, Jokitalo E, Becker JU, Anders HJ.

J Am Soc Nephrol. 2019 Jul 11. pii: ASN.2018121218. doi: 10.1681/ASN.2018121218. [Epub ahead of print]

PMID:
31296606
2.

Intestinal microbiome and fitness in kidney disease.

Meijers B, Evenepoel P, Anders HJ.

Nat Rev Nephrol. 2019 Sep;15(9):531-545. doi: 10.1038/s41581-019-0172-1. Epub 2019 Jun 26. Review.

PMID:
31243394
3.

Nephropathic autoantigens in the spectrum of lupus nephritis.

Anders HJ.

Nat Rev Nephrol. 2019 Jun 13. doi: 10.1038/s41581-019-0168-x. [Epub ahead of print] No abstract available.

PMID:
31197262
4.

Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes.

Lei Y, Devarapu SK, Motrapu M, Cohen CD, Lindenmeyer MT, Moll S, Kumar SV, Anders HJ.

Front Immunol. 2019 May 29;10:1223. doi: 10.3389/fimmu.2019.01223. eCollection 2019.

5.

The gut flora modulates intestinal barrier integrity but not progression of chronic kidney disease in hyperoxaluria-related nephrocalcinosis.

Konrad L, Andersen K, Kesper MS, Kumar SV, Mulay SR, Anders HJ.

Nephrol Dial Transplant. 2019 May 12. pii: gfz080. doi: 10.1093/ndt/gfz080. [Epub ahead of print]

PMID:
31081025
6.

Editorial: Nano- and Microparticle-Induced Cell Death, Inflammation and Immune Responses.

Mulay SR, Herrmann M, Bilyy R, Gabibov A, Anders HJ.

Front Immunol. 2019 Apr 17;10:844. doi: 10.3389/fimmu.2019.00844. eCollection 2019. No abstract available.

7.

Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death.

Silvestre-Roig C, Braster Q, Wichapong K, Lee EY, Teulon JM, Berrebeh N, Winter J, Adrover JM, Santos GS, Froese A, Lemnitzer P, Ortega-Gómez A, Chevre R, Marschner J, Schumski A, Winter C, Perez-Olivares L, Pan C, Paulin N, Schoufour T, Hartwig H, González-Ramos S, Kamp F, Megens RTA, Mowen KA, Gunzer M, Maegdefessel L, Hackeng T, Lutgens E, Daemen M, von Blume J, Anders HJ, Nikolaev VO, Pellequer JL, Weber C, Hidalgo A, Nicolaes GAF, Wong GCL, Soehnlein O.

Nature. 2019 May;569(7755):236-240. doi: 10.1038/s41586-019-1167-6. Epub 2019 May 1.

PMID:
31043745
8.

IL1R8 Deficiency Drives Autoimmunity-Associated Lymphoma Development.

Riva F, Ponzoni M, Supino D, Bertilaccio MTS, Polentarutti N, Massara M, Pasqualini F, Carriero R, Innocenzi A, Anselmo A, Veliz-Rodriguez T, Simonetti G, Anders HJ, Caligaris-Cappio F, Mantovani A, Muzio M, Garlanda C.

Cancer Immunol Res. 2019 Jun;7(6):874-885. doi: 10.1158/2326-6066.CIR-18-0698. Epub 2019 Apr 24.

PMID:
31018956
9.

Treatment Options for Refractory Lupus Nephritis.

Anders HJ, Hiepe F.

Clin J Am Soc Nephrol. 2019 May 7;14(5):653-655. doi: 10.2215/CJN.03230319. Epub 2019 Apr 12. No abstract available.

PMID:
30979714
10.

Surviving Acute Organ Failure: Cell Polyploidization and Progenitor Proliferation.

Lazzeri E, Angelotti ML, Conte C, Anders HJ, Romagnani P.

Trends Mol Med. 2019 May;25(5):366-381. doi: 10.1016/j.molmed.2019.02.006. Epub 2019 Mar 29. Review.

11.

2018 update in basic kidney research: fibrosis, inflammation, glomerular filtration and kidney disease progression.

Anders HJ.

Nephrol Dial Transplant. 2019 May 1;34(5):719-723. doi: 10.1093/ndt/gfz006. No abstract available.

PMID:
30778545
12.

Challenges and opportunities for nephrology in Western Europe.

Rondeau E, Luyckx VA, Anders HJ, Eckardt KU, Florquin S, Marti HP, Ølgaard K, Harden P; members of the Western Europe Regional Board, International Society of Nephrology.

Kidney Int. 2019 May;95(5):1037-1040. doi: 10.1016/j.kint.2018.09.028. Epub 2019 Feb 16. No abstract available.

PMID:
30777285
13.

Refractory lupus nephritis: a survey.

Weidenbusch M, Bai Y, Eder J, Anders HJ; Lupus Nephritis Trials Network.

Lupus. 2019 Apr;28(4):455-464. doi: 10.1177/0961203319828516. Epub 2019 Feb 12.

PMID:
30755142
14.

Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration.

Iwakura T, Zhao Z, Marschner JA, Devarapu SK, Yasuda H, Anders HJ.

Nephrol Dial Transplant. 2019 Jan 8. doi: 10.1093/ndt/gfy397. [Epub ahead of print]

PMID:
30624740
15.

To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps.

Boeltz S, Amini P, Anders HJ, Andrade F, Bilyy R, Chatfield S, Cichon I, Clancy DM, Desai J, Dumych T, Dwivedi N, Gordon RA, Hahn J, Hidalgo A, Hoffmann MH, Kaplan MJ, Knight JS, Kolaczkowska E, Kubes P, Leppkes M, Manfredi AA, Martin SJ, Maueröder C, Maugeri N, Mitroulis I, Munoz LE, Nakazawa D, Neeli I, Nizet V, Pieterse E, Radic MZ, Reinwald C, Ritis K, Rovere-Querini P, Santocki M, Schauer C, Schett G, Shlomchik MJ, Simon HU, Skendros P, Stojkov D, Vandenabeele P, Berghe TV, van der Vlag J, Vitkov L, von Köckritz-Blickwede M, Yousefi S, Zarbock A, Herrmann M.

Cell Death Differ. 2019 Mar;26(3):395-408. doi: 10.1038/s41418-018-0261-x. Epub 2019 Jan 8. Review.

PMID:
30622307
16.

Re-biopsy in lupus nephritis.

Anders HJ.

Ann Transl Med. 2018 Nov;6(Suppl 1):S41. doi: 10.21037/atm.2018.09.47. No abstract available.

17.

MDM2 inhibitor ameliorates cisplatin-induced nephropathy via NFκΒ signal inhibition.

Fujikura T, Yasuda H, Iwakura T, Tsuji T, Anders HJ.

Pharmacol Res Perspect. 2018 Dec 13;7(1):e00450. doi: 10.1002/prp2.450. eCollection 2019 Feb.

18.

Fiend and friend in the renin angiotensin system: An insight on acute kidney injury.

Sharma N, Anders HJ, Gaikwad AB.

Biomed Pharmacother. 2019 Feb;110:764-774. doi: 10.1016/j.biopha.2018.12.018. Epub 2018 Dec 13. Review.

19.

Quantity and Reporting Quality of Kidney Research.

Chatzimanouil MKT, Wilkens L, Anders HJ.

J Am Soc Nephrol. 2019 Jan;30(1):13-22. doi: 10.1681/ASN.2018050515. Epub 2018 Dec 13.

PMID:
30545982
20.

Extracellular traps in kidney disease.

Nakazawa D, Marschner JA, Platen L, Anders HJ.

Kidney Int. 2018 Dec;94(6):1087-1098. doi: 10.1016/j.kint.2018.08.035. Review.

PMID:
30466565
21.

Swimming against the stream: the fishbowl discussion method as an interactive tool for medical conferences: experiences from the 11th European Lupus Meeting.

Mucke J, Anders HJ, Aringer M, Chehab G, Fischer-Betz R, Hiepe F, Lorenz HM, Schwarting A, Specker C, Voll RE, Schneider M.

Ann Rheum Dis. 2019 May;78(5):713-714. doi: 10.1136/annrheumdis-2018-214160. Epub 2018 Nov 2. No abstract available.

PMID:
30389688
22.

CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism.

Romoli S, Angelotti ML, Antonelli G, Kumar Vr S, Mulay SR, Desai J, Anguiano Gomez L, Thomasova D, Eulberg D, Klussmann S, Melica ME, Conte C, Lombardi D, Lasagni L, Anders HJ, Romagnani P.

Kidney Int. 2018 Dec;94(6):1111-1126. doi: 10.1016/j.kint.2018.08.013. Epub 2018 Oct 29.

23.

Genetic mitochondrial glycine amidinotransferase protein aggregate formation triggers microparticle sensing and kidney failure.

Mulay SR, Anders HJ.

Ann Transl Med. 2018 Aug;6(16):315. doi: 10.21037/atm.2018.07.09. No abstract available.

24.

The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease.

Marschner JA, Mulay SR, Steiger S, Anguiano L, Zhao Z, Boor P, Rahimi K, Inforzato A, Garlanda C, Mantovani A, Anders HJ.

Front Immunol. 2018 Sep 25;9:2173. doi: 10.3389/fimmu.2018.02173. eCollection 2018.

25.

Immune mechanisms in the different phases of acute tubular necrosis.

Kundert F, Platen L, Iwakura T, Zhao Z, Marschner JA, Anders HJ.

Kidney Res Clin Pract. 2018 Sep;37(3):185-196. doi: 10.23876/j.krcp.2018.37.3.185. Epub 2018 Sep 30. Review.

26.

IL-22 sustains epithelial integrity in progressive kidney remodeling and fibrosis.

Weidenbusch M, Song S, Iwakura T, Shi C, Rodler S, Kobold S, Mulay SR, Honarpisheh MM, Anders HJ.

Physiol Rep. 2018 Aug;6(16):e13817. doi: 10.14814/phy2.13817.

27.

Activated platelets induce MLKL-driven neutrophil necroptosis and release of neutrophil extracellular traps in venous thrombosis.

Nakazawa D, Desai J, Steiger S, Müller S, Devarapu SK, Mulay SR, Iwakura T, Anders HJ.

Cell Death Discov. 2018 Jun 28;4:6. doi: 10.1038/s41420-018-0073-2. eCollection 2018. Erratum in: Cell Death Discov. 2019 Jul 10;5:116.

28.

Novel Insights into Crystal-Induced Kidney Injury.

Mulay SR, Shi C, Ma X, Anders HJ.

Kidney Dis (Basel). 2018 Jun;4(2):49-57. doi: 10.1159/000487671. Epub 2018 Apr 3. Review.

29.

Murine Double Minute-2 Links Cell Cycle Control and Inflammation in Homeostasis and Disease.

Ebrahim M, Anders HJ.

Am J Pathol. 2018 Sep;188(9):1953-1955. doi: 10.1016/j.ajpath.2018.06.004. Epub 2018 Jun 28.

PMID:
29963992
30.

Necroptosis in Acute Kidney Injury.

Anders HJ.

Nephron. 2018;139(4):342-348. doi: 10.1159/000489940. Epub 2018 May 31.

31.

Correction to: Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 May 24;9(6):622. doi: 10.1038/s41419-018-0638-2.

32.

Author Correction: Particles of different sizes and shapes induce neutrophil necroptosis followed by the release of neutrophil extracellular trap-like chromatin.

Desai J, Foresto-Neto O, Honarpisheh M, Steiger S, Nakazawa D, Popper B, Buhl EM, Boor P, Mulay SR, Anders HJ.

Sci Rep. 2018 Apr 24;8(1):6663. doi: 10.1038/s41598-018-24793-2.

33.

CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease.

Anders HJ, Huber TB, Isermann B, Schiffer M.

Nat Rev Nephrol. 2018 Jun;14(6):361-377. doi: 10.1038/s41581-018-0001-y. Review.

PMID:
29654297
34.

Anti-Transforming Growth Factor β IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney Disease.

Steiger S, Grill JF, Ma Q, Bäuerle T, Jordan J, Smolle M, Böhland C, Lech M, Anders HJ.

Front Immunol. 2018 Mar 29;9:619. doi: 10.3389/fimmu.2018.00619. eCollection 2018.

35.

Toll-like receptors in lupus nephritis.

Devarapu SK, Anders HJ.

J Biomed Sci. 2018 Apr 12;25(1):35. doi: 10.1186/s12929-018-0436-2. Review.

36.

Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury.

Lazzeri E, Angelotti ML, Peired A, Conte C, Marschner JA, Maggi L, Mazzinghi B, Lombardi D, Melica ME, Nardi S, Ronconi E, Sisti A, Antonelli G, Becherucci F, De Chiara L, Guevara RR, Burger A, Schaefer B, Annunziato F, Anders HJ, Lasagni L, Romagnani P.

Nat Commun. 2018 Apr 9;9(1):1344. doi: 10.1038/s41467-018-03753-4.

37.

Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 Mar 2;9(3):359. doi: 10.1038/s41419-018-0394-3. Erratum in: Cell Death Dis. 2018 May 24;9(6):622.

38.

RGMb protects against acute kidney injury by inhibiting tubular cell necroptosis via an MLKL-dependent mechanism.

Liu W, Chen B, Wang Y, Meng C, Huang H, Huang XR, Qin J, Mulay SR, Anders HJ, Qiu A, Yang B, Freeman GJ, Lu HJ, Lin HY, Zheng ZH, Lan HY, Huang Y, Xia Y.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1475-E1484. doi: 10.1073/pnas.1716959115. Epub 2018 Jan 30.

39.

The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury.

Anders HJ, Suarez-Alvarez B, Grigorescu M, Foresto-Neto O, Steiger S, Desai J, Marschner JA, Honarpisheh M, Shi C, Jordan J, Müller L, Burzlaff N, Bäuerle T, Mulay SR.

Kidney Int. 2018 Mar;93(3):656-669. doi: 10.1016/j.kint.2017.09.022. Epub 2017 Dec 12.

40.

Chronic kidney disease.

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders HJ.

Nat Rev Dis Primers. 2017 Nov 23;3:17088. doi: 10.1038/nrdp.2017.88. Review.

PMID:
29168475
41.

Phagocytosis of environmental or metabolic crystalline particles induces cytotoxicity by triggering necroptosis across a broad range of particle size and shape.

Honarpisheh M, Foresto-Neto O, Desai J, Steiger S, Gómez LA, Popper B, Boor P, Anders HJ, Mulay SR.

Sci Rep. 2017 Nov 14;7(1):15523. doi: 10.1038/s41598-017-15804-9.

42.

Reprint of "Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis".

Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ.

Clin Immunol. 2017 Dec;185:119-127. doi: 10.1016/j.clim.2017.10.011. Epub 2017 Oct 28.

PMID:
29111236
43.

Particles of different sizes and shapes induce neutrophil necroptosis followed by the release of neutrophil extracellular trap-like chromatin.

Desai J, Foresto-Neto O, Honarpisheh M, Steiger S, Nakazawa D, Popper B, Buhl EM, Boor P, Mulay SR, Anders HJ.

Sci Rep. 2017 Nov 3;7(1):15003. doi: 10.1038/s41598-017-15106-0. Erratum in: Sci Rep. 2018 Apr 24;8(1):6663.

44.

Gene expression profiling of the Notch-AhR-IL22 axis at homeostasis and in response to tissue injury.

Weidenbusch M, Rodler S, Song S, Romoli S, Marschner JA, Kraft F, Holderied A, Kumar S, Mulay SR, Honarpisheh M, Kumar Devarapu S, Lech M, Anders HJ.

Biosci Rep. 2017 Dec 22;37(6). pii: BSR20170099. doi: 10.1042/BSR20170099. Print 2017 Dec 22.

45.

Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences.

Brix N, Tiefenthaller A, Anders H, Belka C, Lauber K.

Immunol Rev. 2017 Nov;280(1):249-279. doi: 10.1111/imr.12573. Review.

PMID:
29027221
46.

The diabetes pandemic suggests unmet needs for 'CKD with diabetes' in addition to 'diabetic nephropathy'-implications for pre-clinical research and drug testing.

Anguiano Gómez L, Lei Y, Kumar Devarapu S, Anders HJ.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1292-1304. doi: 10.1093/ndt/gfx219.

PMID:
28992221
47.

The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease.

Pollock C, Zuk A, Anders HJ, Ganji MR, Johnson DW, Kasiske B, Langham RG, Pecoits-Filho R, Remuzzi G, Rossert J, Suzuki Y, Tanaka T, Walker R, Yang CW, Bonventre JV.

Kidney Int Suppl (2011). 2017 Oct;7(2):130-137. doi: 10.1016/j.kisu.2017.07.008. Epub 2017 Sep 20. Review.

48.

Tumor necrosis factor superfamily ligand mRNA expression profiles differ between humans and mice during homeostasis and between various murine kidney injuries.

Devarapu SK, Grill JF, Xie J, Weidenbusch M, Honarpisheh M, Vielhauer V, Anders HJ, Mulay SR.

J Biomed Sci. 2017 Sep 19;24(1):77. doi: 10.1186/s12929-017-0383-3.

49.

Introduction: Translational Immunology in Kidney Disease.

Anders HJ, Jayne D, Rovin B.

Semin Nephrol. 2017 Sep;37(5):417. doi: 10.1016/j.semnephrol.2017.05.015. No abstract available.

PMID:
28863789
50.

Molecular Pathophysiology of Gout.

Desai J, Steiger S, Anders HJ.

Trends Mol Med. 2017 Aug;23(8):756-768. doi: 10.1016/j.molmed.2017.06.005. Epub 2017 Jul 18. Review.

PMID:
28732688

Supplemental Content

Loading ...
Support Center